Vladimir Aleshkin
Research Subjects
Research Interests
Vladimir Aleshkin has a total of 286 co-authors. Here are the top co-authors by number of shared publications:
- S. S. Afanasyev
G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology, Moscow, Russia
29 shared publications - Elena A. Voropaeva
G.N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology
20 shared publications Iu V Nesvizhskiĭ
15 shared publications- Alexander Viktorovich Karaulov
Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)
12 shared publications - Andrey V. Aleshkin
“Orphan-Bio” LLC, Krasnodar Region, Sirius, Russian Federation
12 shared publications M S Afanas'Ev
12 shared publications
Latest Publications
- Open Access
- 17 June 2024
- Published by Periodontal Association - RPA in Parodontologiya
Treatment specifics for sialadenosis of the parotid glands in patients undergoing eradication therapy
Relevance. Treating patients with comorbid pathologies of the parotid salivary glands (PSGs) and the gastrointestinal tract presents a significant clinical challenge. Sialadenosis commonly develops in acid-dependent diseases associated with H. pylori (HP) infection, often manifesting as complaints of dry mouth. This condition leads to a reduction in local immunological defense due to decreased levels of sIgA, which is predominantly sourced from parotid secretion. Gastroenterologists typically prescribe eradication therapy that includes a proton pump inhibitor (PPI), which, according to its pharmacodynamic properties, can cause drug-induced xerostomia.Material and methods. A total of 115 individuals with sialadenosis of the PSGs and HP infection, confirmed by a positive urease rapid test in parotid secretion, aged 46.42 ± 6.21 years, were examined. The participants were randomly assigned into groups based on the prescription of absorbable gingival collagen membranes and the dose of a complex immunoglobulin preparation (CIP). The groups were as follows: Group I – 35 individuals without local therapy; Group II – 40 patients receiving 30 mg CIP; Group III – 40 patients receiving 60 mg CIP. Additionally, a control group consisting of 20 healthy individuals aged 44.46 ± 4.12 years was included. Gastroenterologists prescribed a standard triple eradication regimen, which included a proton pump inhibitor (PPI) at double dosage, 1000 mg amoxicillin, and 500 mg clarithromycin, taken twice daily for 14 days. All participants underwent comprehensive dental examinations at various stages: diagnosis, day 14 of eradication, and days 21 and 28 of observation.Results. A significant increase in PSG sialometry and sIgA levels in parotid secretion was observed in patients using absorbable gingival collagen membranes and CIP in addition to standard treatment. At a CIP dose of 60 mg, a negative urease rapid test was determined in parotid secretion by day 14, while at 30 mg, this occurred by day 21, confirming the effectiveness of the therapy.Conclusion. Treating patients with PSG sialadenosis undergoing eradication therapy requires a comprehensive interdisciplinary approach. It is necessary to include absorbable gingival collagen membranes and CIP at a dose of 60 mg twice daily for 21 days.
- 17 June 2024
- Published by Periodontal Association - RPA in Parodontologiya
Open AccessTreatment specifics for sialadenosis of the parotid glands in patients undergoing eradication therapy
Relevance. Treating patients with comorbid pathologies of the parotid salivary glands (PSGs) and the gastrointestinal tract presents a significant clinical challenge. Sialadenosis commonly develops in acid-dependent diseases associated with H. pylori (HP) infection, often manifesting as complaints of dry mouth. This condition leads to a reduction in local immunological defense due to decreased levels of sIgA, which is predominantly sourced from parotid secretion. Gastroenterologists typically prescribe eradication therapy that includes a proton pump inhibitor (PPI), which, according to its pharmacodynamic properties, can cause drug-induced xerostomia.Material and methods. A total of 115 individuals with sialadenosis of the PSGs and HP infection, confirmed by a positive urease rapid test in parotid secretion, aged 46.42 ± 6.21 years, were examined. The participants were randomly assigned into groups based on the prescription of absorbable gingival collagen membranes and the dose of a complex immunoglobulin preparation (CIP). The groups were as follows: Group I – 35 individuals without local therapy; Group II – 40 patients receiving 30 mg CIP; Group III – 40 patients receiving 60 mg CIP. Additionally, a control group consisting of 20 healthy individuals aged 44.46 ± 4.12 years was included. Gastroenterologists prescribed a standard triple eradication regimen, which included a proton pump inhibitor (PPI) at double dosage, 1000 mg amoxicillin, and 500 mg clarithromycin, taken twice daily for 14 days. All participants underwent comprehensive dental examinations at various stages: diagnosis, day 14 of eradication, and days 21 and 28 of observation.Results. A significant increase in PSG sialometry and sIgA levels in parotid secretion was observed in patients using absorbable gingival collagen membranes and CIP in addition to standard treatment. At a CIP dose of 60 mg, a negative urease rapid test was determined in parotid secretion by day 14, while at 30 mg, this occurred by day 21, confirming the effectiveness of the therapy.Conclusion. Treating patients with PSG sialadenosis undergoing eradication therapy requires a comprehensive interdisciplinary approach. It is necessary to include absorbable gingival collagen membranes and CIP at a dose of 60 mg twice daily for 21 days.
- 1 January 2023
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 92 (2) , 97-108
Cow colostrum: component composition, biological properties and application practice
Молозиво коров: компонентный состав, биологические свойства и практика применения
- 1 January 2023
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 92 (2) , 97-108
Cow colostrum: component composition, biological properties and application practice
Молозиво коров: компонентный состав, биологические свойства и практика применения
- 4 May 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Health Care of the Russian Federation
- Vol. 66 (2) , 160-167
Colostrum of cattle in the prevention of human infectious disease (literature review)
Colostrum (or immune milk) is the first milk that mammals produce after childbirth, and its composition differs markedly from milk obtained later in lactation. Colostrum is a rich source of immunoglobulins and other biologically active components. The purpose of this literature review is to systematize research on methods of treatment and prevention of human infectious diseases using immunomodulatory and immunoprotective properties of colostrum. The open sources hosted in PubMed, Researchgate and eLibrary databases were studied. The history of the use of colostrum from hyperimmunized cows as a treatment for human diseases can be traced back to the 1950s. Many studies on the use of colostrum have explored its potential in both the prevention and treatment of various infectious diseases. The data obtained indicate the high efficiency of the use of cow colostrum and its components both for the prevention and treatment of infectious diseases. Colostrum is capable of producing a heterologous transfer of passive immunity. The immunization protocols used in the production of immune milk can be highly variable. This is especially true for the timing of immunization. Working on immunization protocols that expose animals to specific antigens can result in enhanced humoral immune responses in the mammary gland. The most relevant is the search for ways to use immune milk as a means to contain the SARS-CoV-2 pandemic. The literature review provides a description of antimicrobial, immunomodulatory and growth-stimulating factors in bovine colostrum. Examples and descriptions of homologous and heterologous transmission of passive immunity are given.
- 4 May 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Health Care of the Russian Federation
- Vol. 66 (2) , 160-167
Colostrum of cattle in the prevention of human infectious disease (literature review)
Colostrum (or immune milk) is the first milk that mammals produce after childbirth, and its composition differs markedly from milk obtained later in lactation. Colostrum is a rich source of immunoglobulins and other biologically active components. The purpose of this literature review is to systematize research on methods of treatment and prevention of human infectious diseases using immunomodulatory and immunoprotective properties of colostrum. The open sources hosted in PubMed, Researchgate and eLibrary databases were studied. The history of the use of colostrum from hyperimmunized cows as a treatment for human diseases can be traced back to the 1950s. Many studies on the use of colostrum have explored its potential in both the prevention and treatment of various infectious diseases. The data obtained indicate the high efficiency of the use of cow colostrum and its components both for the prevention and treatment of infectious diseases. Colostrum is capable of producing a heterologous transfer of passive immunity. The immunization protocols used in the production of immune milk can be highly variable. This is especially true for the timing of immunization. Working on immunization protocols that expose animals to specific antigens can result in enhanced humoral immune responses in the mammary gland. The most relevant is the search for ways to use immune milk as a means to contain the SARS-CoV-2 pandemic. The literature review provides a description of antimicrobial, immunomodulatory and growth-stimulating factors in bovine colostrum. Examples and descriptions of homologous and heterologous transmission of passive immunity are given.
- 30 April 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 101 (4) , 412-417
On the possibility of using a food product based on colostrum on the health of workers employed in hazardous working conditions (literature review)
Currently, the biological value of colostrum is generally considered as a resource of biotechnologies for the production of functional food products capable of purposefully improving the state of actual nutrition of certain categories of the population. At the same time, the use of essential micronutrients included in colostrum is significantly limited by the complexity of technological processes for the manufacture of biologically active additives based on a natural product. The article is devoted to the generalization and systematization of available information about the macronutrient composition of colostrum, the biological value of essential micronutrients included in the product, immunomodulatory, regulatory and prebiotic properties. The authors present examples of the use of colostrum and its fractions in the form of medicines and biologically active food additives. The possibilities of using a functional food product based on colostrum in industrial workers as a physiologically functional food ingredient with antioxidant effect, radioprotective properties, the possibility of neutralizing xenobiotics, binding heavy metals, arsenic compounds, cyanides, aromatic hydrocarbons are substantiated. The resource for information search is the bibliographic databases Medline and RSCI.
- 30 April 2022
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Hygiene and sanitation
- Vol. 101 (4) , 412-417
On the possibility of using a food product based on colostrum on the health of workers employed in hazardous working conditions (literature review)
Currently, the biological value of colostrum is generally considered as a resource of biotechnologies for the production of functional food products capable of purposefully improving the state of actual nutrition of certain categories of the population. At the same time, the use of essential micronutrients included in colostrum is significantly limited by the complexity of technological processes for the manufacture of biologically active additives based on a natural product. The article is devoted to the generalization and systematization of available information about the macronutrient composition of colostrum, the biological value of essential micronutrients included in the product, immunomodulatory, regulatory and prebiotic properties. The authors present examples of the use of colostrum and its fractions in the form of medicines and biologically active food additives. The possibilities of using a functional food product based on colostrum in industrial workers as a physiologically functional food ingredient with antioxidant effect, radioprotective properties, the possibility of neutralizing xenobiotics, binding heavy metals, arsenic compounds, cyanides, aromatic hydrocarbons are substantiated. The resource for information search is the bibliographic databases Medline and RSCI.
- Open Access
- 29 October 2019
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 21 (4) , 595-602
LECTIN-DEPENDENT DIVERSITY OF NATURAL KILLER POPULATIONS AND COMMUNICATIONS AGAINST TUMORS AND VIRUSES
ЗАВИСИМОЕ ОТ ЛЕКТИНОВ РАЗНООБРАЗИЕ ПОПУЛЯЦИЙ ПРИРОДНЫХ КИЛЛЕРНЫХ КЛЕТОК В КОММУНИКАЦИЯХ ПРОТИВ ОПУХОЛЕЙ И ВИРУСОВ
- 29 October 2019
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 21 (4) , 595-602
Open AccessLECTIN-DEPENDENT DIVERSITY OF NATURAL KILLER POPULATIONS AND COMMUNICATIONS AGAINST TUMORS AND VIRUSES
ЗАВИСИМОЕ ОТ ЛЕКТИНОВ РАЗНООБРАЗИЕ ПОПУЛЯЦИЙ ПРИРОДНЫХ КИЛЛЕРНЫХ КЛЕТОК В КОММУНИКАЦИЯХ ПРОТИВ ОПУХОЛЕЙ И ВИРУСОВ
- Open Access
- 7 October 2019
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 64 (5) , 314-320
LECTIN POPULATIONS OF NK CELLS AGAINST VIRUSES-ASSOCIATED TUMORS (REVIEW OF LITERATURE)
Analysis of the human NK (natural killers) cells and their functionally different populations in connection to tumor processes accompanied with viral infections is presented. Receptor lectins (non-immunoglobulin proteins and their complexes recognizing polysaccharides, glycoconjugates and glycopattern-containing molecules) play important role in regulation of innate immunity. Communicative diversity of NK-cell populations (in which lectins cofunction to other receptors) is directed against tumors and viruses. Effectiveness and selectivity of action of NK cell populations can be increased in cooperation together with adaptive immunity. Evaluations of occurrence, redistribution (also under influence of cytokines) and contribution of NK-populations (depending on lectin receptors recognition coupled to multifunctions of receptors) in respect of increasing antitumor and antiviral immune responces are given. The data indicate extended prospects of lectin receptors (coupled to other type receptors) containing NK populations of the network compartment of innate immunity upon realization of different variants of organism protection in cooperation with cellular and humoral immunity. Such NK populations are the basis for further intercellular interactions. Innate immunity Cross-Talk, involving the leader NK cell populations acting according to humoral immunity mechanisms, acts on duty regime (importance for therapy of chronic pathology) that results in providing optimal combined antitumor and antiviral cytokine and cytotoxic responses according to the principle of action as «network-in-network». The influence network of lectin, Ig-like, cytotoxic, other regulator NK populations (also throuph redistribution of production of cytokines by immunocompetent cells) is perspective for forming early prolongated antitumor and antiviral processes of different types in organism. It is of importance to consider CD diversity of receptor repertuar of lectin, Ig-like and other NK populations revealing different ontogenesis as well as to seach patient key NK-populations to select and construct personally (or for contingents in cases of epidemiological significance) optimal therapeutic/prophylactic NK populations (like variants of CAR-T). Aforementioned data indicate perspectiveness of NK cell populations in development of new antitumor/antiviral effective and selective vaccine strategies, preparations and regimes of their applications. Probiotic lectins reveal features of perspective ligands cofunctioning to network of NK cell populations.
- 7 October 2019
- Published by EKOlab in Russian Clinical Laboratory Diagnostics
- Vol. 64 (5) , 314-320
Open AccessLECTIN POPULATIONS OF NK CELLS AGAINST VIRUSES-ASSOCIATED TUMORS (REVIEW OF LITERATURE)
Analysis of the human NK (natural killers) cells and their functionally different populations in connection to tumor processes accompanied with viral infections is presented. Receptor lectins (non-immunoglobulin proteins and their complexes recognizing polysaccharides, glycoconjugates and glycopattern-containing molecules) play important role in regulation of innate immunity. Communicative diversity of NK-cell populations (in which lectins cofunction to other receptors) is directed against tumors and viruses. Effectiveness and selectivity of action of NK cell populations can be increased in cooperation together with adaptive immunity. Evaluations of occurrence, redistribution (also under influence of cytokines) and contribution of NK-populations (depending on lectin receptors recognition coupled to multifunctions of receptors) in respect of increasing antitumor and antiviral immune responces are given. The data indicate extended prospects of lectin receptors (coupled to other type receptors) containing NK populations of the network compartment of innate immunity upon realization of different variants of organism protection in cooperation with cellular and humoral immunity. Such NK populations are the basis for further intercellular interactions. Innate immunity Cross-Talk, involving the leader NK cell populations acting according to humoral immunity mechanisms, acts on duty regime (importance for therapy of chronic pathology) that results in providing optimal combined antitumor and antiviral cytokine and cytotoxic responses according to the principle of action as «network-in-network». The influence network of lectin, Ig-like, cytotoxic, other regulator NK populations (also throuph redistribution of production of cytokines by immunocompetent cells) is perspective for forming early prolongated antitumor and antiviral processes of different types in organism. It is of importance to consider CD diversity of receptor repertuar of lectin, Ig-like and other NK populations revealing different ontogenesis as well as to seach patient key NK-populations to select and construct personally (or for contingents in cases of epidemiological significance) optimal therapeutic/prophylactic NK populations (like variants of CAR-T). Aforementioned data indicate perspectiveness of NK cell populations in development of new antitumor/antiviral effective and selective vaccine strategies, preparations and regimes of their applications. Probiotic lectins reveal features of perspective ligands cofunctioning to network of NK cell populations.
- Open Access
- 17 May 2019
- Published by SPRIDA in Journal Infectology
- Vol. 11 (2) , 45-52
Identification of Bordetella holmesii among the patients hospitalized with suspicion of pertussis and pertussis-like illnesses
Purpose.To reveal and estimate prevalence of B. holmesii among the patients hospitalized with suspicion pertussis and pertussis-like illnesses.Materials and methods. 424 clinical samples received from patients with of pertussis and pertussis-like illnesses in GBUZ IKB № 1 DZM in 2017–2018 are investigated. Identification of fragments of a genome of Bordetella was carried out in PCR-RT with “Amplisens® Bordetella multi-FL”. For identification of fragments of a genome of B. holmesii used PCR-RT with primers of IS481, IS1001 and hIS1001.Results.The research included 424 patients, from them 56,1% of children aged till 1 year, 41,3% of children – are more senior than 1 year and 2,6% of adults. When using test system 60,4% of the samples containing DNA of B. pertussis are revealed; 1,9% of samples – DNA of B. parapertussis; in 34,9% of samples it is received negative and in 2,8% – doubtful results. The research of 424 samples in PCR-RT by means of IS481, IS1001 and hIS1001 primers showed that 61,1% of samples contained DNA of B. pertussis; 0,7% of samples – DNA of B. parapertussis and 3,8% of samples – DNA of B. holmesii. In 143 samples the result was negative. From 16 DNA of B. holmesii – positive samples, 9 samples were negative in test system earlier, in 2 samples – the doubtful result, 1 sample was earlier identified as DNA of B. parapertussis and in 4 samples DNA of B. pertussis and B. holmesii are found.Conclusion.The research demonstrates circulation of B. holmesii in the territory of Russia that is confirmed by identification of positive samples in 3,8% of cases among the sick children and adults hospitalized in a hospital with suspicion of pertussis and pertussis-like illnesses. For increase in efficiency of laboratory confirmation of the clinical diagnosis of pertussis and pertussis-like illnesses the genodiagnostic of a pertussis is recommended to improve taking into account identification DNA of B. holmesii.
- 17 May 2019
- Published by SPRIDA in Journal Infectology
- Vol. 11 (2) , 45-52
Open AccessIdentification of Bordetella holmesii among the patients hospitalized with suspicion of pertussis and pertussis-like illnesses
Purpose.To reveal and estimate prevalence of B. holmesii among the patients hospitalized with suspicion pertussis and pertussis-like illnesses.Materials and methods. 424 clinical samples received from patients with of pertussis and pertussis-like illnesses in GBUZ IKB № 1 DZM in 2017–2018 are investigated. Identification of fragments of a genome of Bordetella was carried out in PCR-RT with “Amplisens® Bordetella multi-FL”. For identification of fragments of a genome of B. holmesii used PCR-RT with primers of IS481, IS1001 and hIS1001.Results.The research included 424 patients, from them 56,1% of children aged till 1 year, 41,3% of children – are more senior than 1 year and 2,6% of adults. When using test system 60,4% of the samples containing DNA of B. pertussis are revealed; 1,9% of samples – DNA of B. parapertussis; in 34,9% of samples it is received negative and in 2,8% – doubtful results. The research of 424 samples in PCR-RT by means of IS481, IS1001 and hIS1001 primers showed that 61,1% of samples contained DNA of B. pertussis; 0,7% of samples – DNA of B. parapertussis and 3,8% of samples – DNA of B. holmesii. In 143 samples the result was negative. From 16 DNA of B. holmesii – positive samples, 9 samples were negative in test system earlier, in 2 samples – the doubtful result, 1 sample was earlier identified as DNA of B. parapertussis and in 4 samples DNA of B. pertussis and B. holmesii are found.Conclusion.The research demonstrates circulation of B. holmesii in the territory of Russia that is confirmed by identification of positive samples in 3,8% of cases among the sick children and adults hospitalized in a hospital with suspicion of pertussis and pertussis-like illnesses. For increase in efficiency of laboratory confirmation of the clinical diagnosis of pertussis and pertussis-like illnesses the genodiagnostic of a pertussis is recommended to improve taking into account identification DNA of B. holmesii.
- Open Access
- 1 March 2019
- Published by Federal Scientific Center for Medical and Preventive Health Risk Management Technologies in Health Risk Analysis
- No. 1,p. 144-153
NK-cells that identify glycopatterns and their anti-tumor potential against a background of epidemically significant viral infections
- 1 March 2019
- Published by Federal Scientific Center for Medical and Preventive Health Risk Management Technologies in Health Risk Analysis
- No. 1,p. 144-153
Open AccessNK-cells that identify glycopatterns and their anti-tumor potential against a background of epidemically significant viral infections
- Open Access
- 1 March 2019
- Published by Federal Scientific Center for Medical and Preventive Health Risk Management Technologies in Health Risk Analysis
- No. 1,p. 144-153
NK-cells that identify glycopatterns and their anti-tumor potential against a background of epidemically significant viral infections
- 1 March 2019
- Published by Federal Scientific Center for Medical and Preventive Health Risk Management Technologies in Health Risk Analysis
- No. 1,p. 144-153
Open AccessNK-cells that identify glycopatterns and their anti-tumor potential against a background of epidemically significant viral infections